Abbott Laboratories Slammed On Its Post-Exact Sciences Guidance:
Abbott stock took a hit early Thursday on lackluster guidance for the year and second quarter ...
investors.com/news/technology/abbott-laboratories-stock-abbott-laboratories-earnings-q1-2026/
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
American global health care and medical device products company
Similar to This
Previous
Barron's Oct 21
Paid articlePaywall Abbott to Spin Off Troubled Nutrition Unit to Focus on Growth: Abbott Laboratories plans to separate its global nutrition business into an independent ...
barrons.com/articles/abbott-labs-earnings-stock-price-spinoff-4179c9e7
Company behind 2022 formula shortage to pay $384M over tainted formula: Abbott Laboratories agreed to pay $384M to settle federal and state allegations of ...
al.com/news/2026/09/company-behind-2022-formula-shortage-to-pay-384m-over-tainted-formula.html
Boston Scientific Slammed After Cyberattack Hamstrings Sales, Profit: Boston Scientific said Tuesday a cybersecurity incident is likely to have a material impact ...
investors.com/news/technology/boston-scientific-cybersecurity-attack-guidance/
How Abbott Labs Is Embracing RFK Jr.'s Make America Healthy Again Movement: Abbott Laboratories is leaning into the Make America Healthy Movement ...
investors.com/news/technology/abbott-laboratories-liquid-whole-milk-infant-formula/
New rapid tests fight deadly infections in Africa: Kenya has achieved over 90 per cent screening coverage for HIV and syphilis in antenatal care and is now ...
standardmedia.co.ke/health/health-science/article/2001548638/new-rapid-tests-fight-deadly-infections-in-africa
Jim Cramer has a stark message on the stock market for 2026: Jim Cramer warned on Mad Money that 2026 is more punishing than 1999. Here are his exact words ...
thestreet.com/investing/stocks/jim-cramer-has-a-stark-message-on-the-stock-market-for-2026
OpinionDr. Alexander Crider: There is a hidden cost to the Abbott verdict for premature babies
chicagotribune.com/2026/04/17/opinion-abbott-laboratories-cook-county-verdict-premature-infants/
Barron's Apr 16
Paid articlePaywall Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting.
barrons.com/articles/abbott-labs-earnings-stock-price-c7c75582
The Globe and Mail Apr 16
Abbott trims 2026 profit forecast on Exact deal hit, shares fall: Medical device maker now expects adjusted profit per share between US$5.38 and US$5.58 ...
theglobeandmail.com/business/article-abbott-trims-2026-profit-forecast-on-exact-deal-hit-shares-fall/
Inside the high-stakes corporate fight over feeding preterm babies: Abbott and Mead Johnson have turned NICUs into arenas of brutal competition.
pressdemocrat.com/2026/04/14/inside-the-high-stakes-corporate-fight-over-feeding-preterm-babies/
Inside the high-stakes corporate fight over feeding preterm babies: A look at Abbott and Mead Johnson's rivalry over NICU fortifiers, AL16 trial findings ...
miamiherald.com/news/health-care/article315355630.html
The Minnesotan behind Cologuard, which fueled the biggest health care acquisition of 2025
startribune.com/abbott-acquisition/601536926
Abbott is buying Exact Sciences. Here’s why
modernhealthcare.com/medical-devices/mh-abbott-laboratories-exact-sciences-robert-ford/
Exact Sciences Catapults On $23 Billion Abbott Labs Buyout: Exact Sciences stock rocketed for a second day Thursday, after Abbott Laboratories confirmed a $23 ...
investors.com/news/technology/exact-sciences-stock-abbott-laboratories-rumored-takeover/
Paid articlePaywall Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test
marketwatch.com/story/why-abbott-is-paying-21-billion-for-exact-sciences-and-its-cologuard-cancer-test-43dd31f9
Abbott is weighing takeover of Exact Sciences, Bloomberg News reports: Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test ...
reuters.com/business/healthcare-pharmaceuticals/abbott-is-weighing-takeover-exact-sciences-bloomberg-news-reports-2025-11-19/
Abbott to buy Madison-based Exact Sciences in deal valued at up to $23 billion: The deal will add the cancer test Cologuard to Abbott's portfolio.
eu.jsonline.com/story/news/2025/11/20/abbott-to-buy-madison-based-exact-sciences-in-up-to-23-billion-deal/87370349007/
Exact Sciences Tumbles On Plans To License Blood-Based Colon Cancer Test: Exact Sciences stock crashed Wednesday after the company inked a deal for the exclusive ...
investors.com/news/technology/exact-sciences-stock-exact-sciences-earnings-q2-2025-freenome-blood-test/
Exact Sciences blood test for many cancers is going to patients this summer: Meanwhile, a competitor has received federal approval for a stool-based colon cancer ...
omaha.com/life-entertainment/nation-world/wellness/exact-sciences-cancer-blood-test/article_f79c1fcc-aa14-5c41-bf83-5d7014257398.html
Next